Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (TSXV:RX)

VANC Pharmaceuticals could earn 75% net margin with OTC iron supplement

The Life Sciences Report March 29, 2016

Most oil storage in at least 80 years?

Stockhouse Editorial April 1, 2015

Bullboard Posts (TSXV:RX)

Rivemont MicroCap Cocktail Event (September 2023)

https://www.youtube.com/watch?v=9AHlGi9e2RM
Possibleidiot01 - October 18, 2023

New Planet Microcap Presentation

BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada - YouTube
Daudau11 - September 19, 2023

BioSyent Pharma to Introduce Gelclair®

https://www.globenewswire.com/news-release/2023/07/06/2700870/0/en/BioSyent-Pharma-to-Introduce-Gelclair-at-AHNS-11th-International...
lscfa - July 7, 2023

BioSyent Long-term Extension of Cathejell® Agreement

MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce...
Betteryear2 - June 20, 2023

Presenting at Bloom Burton Conf.

April 25   https://www.bloomburton.com/conference/  
lscfa - April 18, 2023

Launch of New FeraMAX® Pd Maintenance 45

https://stockhouse.com/news/press-releases/2023/03/07/biosyent-announces-launch-of-new-xa0-feramax-xae-pd-maintenance-45
lscfa - March 7, 2023